(Reuters) - AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and ...
Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant. While the elderly and those who are ...
AstraZeneca and the University of Oxford on Sunday began new trials to test a modified vaccine against the Beta variant, which first emerged in South Africa. The 'booster' vaccine's trial will involve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback